Kuusela Kati, Norppa Niina, Auranen Annika, Saarelainen Sami
Tampere University, FI-33014, Tampere, Finland.
Tampere University Hospital, Department of Obsteterics and Gynecology, PO BOX 2000, FI-33521, Tampere, Finland.
Eur J Surg Oncol. 2022 Dec;48(12):2525-2530. doi: 10.1016/j.ejso.2022.06.007. Epub 2022 Jun 9.
Surgery is the cornerstone of the treatment for advanced ovarian cancer. Reaching complete cytoreduction resulting in no gross residual disease often requires complex surgery. The aim of this study was to assess the impact of increased surgical radicality on the risk of complications in the treatment of advanced ovarian cancer.
All consecutive patients with advanced ovarian cancer (FIGO Stage IIIB-IVB) who had undergone primary or interval debulking surgery during a six-year study period were identified. In the midst of the study period, a surgical practice change towards maximal surgical effort occurred. Two groups were formed for the analysis: cohort A, that consisted of patients operated before the surgical paradigm shift and cohort B, that consisted of patients operated under the period of increased surgical radicality.
252 patients were included in the analysis. Complete resection (R0) was achieved in 21.3% of surgeries in cohort A and in 51.2% in cohort B. The total postoperative complication rate was 76.2%. Most of the complications (86.5%) were minor (Clavien-Dindo I-IIIA). The patients in cohort B were at increased risk for complications, OR 2.94 (95%CI 1.58-5.47; p = 0.001). As for the approach to cytoreduction (primary vs. interval debulking), there was no statistically significant association with the occurrence of postoperative complications (p = 0.659).
In the present study more extensive surgeries led to better surgical results but increased postoperative morbidity. Postoperative complication rates were similar in both primary and interval debulking surgeries.
手术是晚期卵巢癌治疗的基石。实现完全细胞减灭术从而无肉眼可见残留病灶通常需要复杂的手术。本研究的目的是评估在晚期卵巢癌治疗中增加手术彻底性对并发症风险的影响。
确定了在为期六年的研究期间接受初次或间隔性肿瘤细胞减灭术的所有连续晚期卵巢癌患者(国际妇产科联盟(FIGO)分期IIIB-IVB)。在研究期间,手术实践向最大程度的手术努力发生了转变。形成两组进行分析:队列A,由手术模式转变前接受手术的患者组成;队列B,由在手术彻底性增加时期接受手术的患者组成。
252例患者纳入分析。队列A中21.3%的手术实现了完全切除(R0),队列B中这一比例为51.2%。术后总并发症发生率为76.2%。大多数并发症(86.5%)为轻度(Clavien-Dindo I-IIIA级)。队列B中的患者发生并发症的风险增加,比值比为2.94(95%置信区间1.58-5.47;p = 0.001)。至于细胞减灭术的方式(初次与间隔性肿瘤细胞减灭术),与术后并发症的发生无统计学显著关联(p = 0.659)。
在本研究中,更广泛的手术带来了更好的手术效果,但术后发病率增加。初次和间隔性肿瘤细胞减灭术的术后并发症发生率相似。